New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis - 1/20/15

Existing cancer therapies are geared toward massacring tumor cells, but Johns Hopkins researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body.
Source: Johns Hopkins Medicine News - Category: Research Source Type: news

Related Links:

Publication date: Available online 18 January 2019Source: Materials Science and Engineering: CAuthor(s): Dnyaneshwar Kalyane, Nidhi Raval, Rahul Maheshwari, Vishakha Tambe, Kiran Kalia, Rakesh K. TekadeAbstractIn tumorous tissues, the absence of vasculature supportive tissues intimates the formation of leaky vessels and pores (100 nm to 2 μm in diameter) and the poor lymphatic system offers great opportunity to treat cancer and the phenomenon is known as Enhanced permeability and retention (EPR) effect. The trends in treating cancer by making use of EPR effect is increasing day by day and generate multitudes of poss...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
The physical and psychological side effects of breast cancer therapies can have substantial impact on survivors' physical and social functioning. Roughly half of the more than 3 million Americans alive with a history of breast cancer report adverse, function-degrading sequelae related to their oncologic treatments. Care delivery models for the timely delivery of rehabilitation services have been proposed yet limitedly vetted or implemented. These include the prospective surveillance model, procedure-linked referrals, survivorship care plans, and risk stratification. Patients' capacity to engage in the rehabilitative proces...
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: Literature Review Source Type: research
CONCLUSIONS TCL-based immunotherapy has discrepant anti-tumor efficiency in different TNBC cell lines by PDL-1/PD interaction, providing the theoretical basis of TCL-based immunotherapy in TNBC. PMID: 30653481 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
by Craig Klugman, Ph.D. Jump to The Resident (Season 2; Episode 10): What would you do doctor?a>;Jump to The Good Doctor (Season 1; Episode 11): Ignoring patient rights; unnecessary risks; crisis planning; Jump to New Amsterdam (Season 1; Episode 11): Superutilizers and racism; Jump to Chicago Med (Season 4; Episode 11): Triage, gestational surrogacy conflicts; ends justifies the means The Resident (Season 2; Episode 10): What would you do doctor? As Hunter is released from prison on murder charges for killing patients with unneeded cancer therapy (sometimes on people without cancer), one of her victims is in the ED wit...
Source: - Category: Medical Ethics Authors: Tags: BioethicsTV Conflict of Interest Decision making End of Life Care Featured Posts Informed Consent professional ethics Public Health Reproductive Ethics Source Type: blogs
In this study, hyaluronic acid (HA) conjugated bovine serum albumin (BSA) nanoparticles have been synthesized according to AmiNoAcid Decorated and Light Underpinning Conjugation Approach (ANADOLUCA) that provides microemulsion polymerization at room temperature, under a nitrogen atmosphere in daylight. The synthesized nano BSA-HA particles have been characterized by Circular Dichroism (CD), Scanning Electron Microscopy (SEM), fluorescence spectrum and thermal gravimetric analysis. Then, nano BSA-HA particles have been used in vitro cytotoxicity analysis and imaging of PANC-1 ATCC® CRL146 cells. Cytotoxic effect of nano...
Source: Protein and Peptide Letters - Category: Biochemistry Authors: Tags: Protein Pept Lett Source Type: research
CONCLUSION: Powerful strategies able to selectively interfere with its expression and function should reveal helpful in the development of new anti-cancer therapies. PMID: 30652649 [PubMed - as supplied by publisher]
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research
After pioneering a targeted cancer therapy, he oversaw MD Anderson in Houston as it gained a reputation as the nation ’ s top cancer hospital.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Mendelsohn, John Deaths (Obituaries) University of Texas M D Anderson Cancer Center Erbitux (Drug) ImClone Systems Inc Source Type: news
Eli Lilly and Co said its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial and it expects to take a charge in the first quarter of 2019, sending its shares down more than 2 percent in early trade.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
ACS NanoDOI: 10.1021/acsnano.9b00294
Source: ACS Nano - Category: Nanotechnology Authors: Source Type: research
Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy. Especially...
Source: BMC Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Research